Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Losartan can cause temporary loss of taste.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Male pattern baldness may predict prostate cancer risk.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Effective PCOS management needs clear roles between primary and specialist care, digital tools, and patient education.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

CEC levels may be a useful marker for predicting prostate cancer progression.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Gene variation affects prostate issues and hair loss.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Using finasteride with TIP extends time off period for prostate cancer patients.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Certain genetic markers may increase or decrease prostate cancer risk.

Serum triglyceride levels are not linked to prostate cancer risk.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.